Bardet-Biedl Syndrome-7 () Shows Treatment Potential and a Cone-rod Dystrophy Phenotype That Recapitulates the Non-human Primate Model
Overview
Ophthalmology
Authors
Affiliations
: To provide a detailed ophthalmic phenotype of two male patients with Bardet-Biedl Syndrome (BBS) due to mutations in the gene: Two brothers ages 26 (Patient 1, P1) and 23 (P2) underwent comprehensive ophthalmic evaluations over three years. Visual function was assessed with full-field electroretinograms (ffERGs), kinetic and chromatic perimetry, multimodal imaging with spectral domain optical coherence tomography (SD-OCT), fundus autofluorescence (FAF) with short- (SW) and near-infrared (NIR) excitation lights and adaptive optics scanning light ophthalmoscopy (AOSLO).: Both siblings had a history of obesity and postaxial polydactyly; P2 had diagnoses of type 1 Diabetes Mellitus, Addison's disease, high-functioning autism-spectrum disorder and -12D myopia. Visual acuities were better than 20/30. Kinetic fields were moderately constricted. Cone-mediated ffERGs were undetectable, rod ERGs were ~80% of normal mean. Static perimetry showed severe central cone and rod dysfunction. Foveal to parafoveal hypoautofluorescence, most obvious on NIR-FAF, co-localized with outer segment shortening/loss and outer nuclear layer thinning by SD-OCT, and with reduced photoreceptors densities by AOSLO. A structural-functional dissociation was confirmed for cone- and rod-mediated parameters. Worsening of the above abnormalities was documented by SD-OCT and FAF in P2 at 3 years. Gene screening identified compound heterozygous mutations in (p.Val266Glu: c.797 T > A of maternal origin; c.1781_1783delCAT, paternal) in both patients.: -associated retinal degeneration may present as a progressive cone-rod dystrophy pattern, reminiscent of both the murine and non-human primate models of the disease. Predominantly central retinal abnormalities in both cone and rod photoreceptors showed a structural-functional dissociation, an ideal scenario for gene augmentation treatments.
Kellner S, Weinitz S, Farmand G, Kellner U J Clin Med. 2024; 13(22).
PMID: 39598030 PMC: 11594703. DOI: 10.3390/jcm13226886.
Nonhuman primate genetic models for the study of rare diseases.
Vallender E, Hotchkiss C, Lewis A, Rogers J, Stern J, Peterson S Orphanet J Rare Dis. 2023; 18(1):20.
PMID: 36721163 PMC: 9887761. DOI: 10.1186/s13023-023-02619-3.
Retinal Degeneration Animal Models in Bardet-Biedl Syndrome and Related Ciliopathies.
Delvallee C, Dollfus H Cold Spring Harb Perspect Med. 2023; 13(1).
PMID: 36596648 PMC: 9808547. DOI: 10.1101/cshperspect.a041303.
Progressive retinal degeneration of rods and cones in a Bardet-Biedl syndrome type 10 mouse model.
Mayer S, Thomas J, Helms M, Kothapalli A, Cherascu I, Salesevic A Dis Model Mech. 2022; 15(9).
PMID: 36125046 PMC: 9536196. DOI: 10.1242/dmm.049473.
Ophthalmic and Genetic Features of Bardet Biedl Syndrome in a German Cohort.
Nasser F, Kohl S, Kurtenbach A, Kempf M, Biskup S, Zuleger T Genes (Basel). 2022; 13(7).
PMID: 35886001 PMC: 9322102. DOI: 10.3390/genes13071218.